During the past decade, LKI Lungenfachklinik Immenhausen conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "LKI Lungenfachklinik Immenhausen" are "EGFR Exon 19 Deletion" (1 trials), "EGFR L858R" (1 trials), "Non-Small Cell Lung Cancer (NSCLC)" (1 trials) and "Nonsquamous Non-small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "LKI Lungenfachklinik Immenhausen" in a lesser frequency.

Most popular intervention types in "LKI Lungenfachklinik Immenhausen" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Patritumab Deruxtecan" (1 trials), "Pemigatinib" (1 trials) and "Platinum-based chemotherapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "LKI Lungenfachklinik Immenhausen" are 2 trials for "All" genders.

Currently, there are NaN active trials in "LKI Lungenfachklinik Immenhausen". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in LKI Lungenfachklinik Immenhausen, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in LKI Lungenfachklinik Immenhausen, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".